H3K9me3 | H4K20me3 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
score | 0 | 1+ | 2+ | score | 0 | 1+ | 2+ | ||||
N = 71 | 25 | 22 | 24 | N = 93 | 36 | 23 | 34 | ||||
35.2 | 31.0 | 33.8 | (%) | 38.7 | 24.7 | 36.6 | (%) | ||||
N | P* | N | P* | ||||||||
Pathological classification | 71 | 0.503 | Pathological classification | 93 | 0.478 | ||||||
DCIS, microinvasive | 1 | 5 | 3 | DCIS, microinvasive | 1 | 3 | 4 | ||||
idc, pap | 9 | 9 | 7 | idc, pap | 11 | 8 | 10 | ||||
idc, sol | 4 | 3 | 3 | idc, sol | 10 | 3 | 3 | ||||
idc, sci | 8 | 2 | 6 | idc, sci | 8 | 4 | 10 | ||||
special type | 3 | 3 | 5 | special type | 6 | 5 | 7 | ||||
Lymph node metastasis | 64 | 0.493 | Lymph node metastasis | 83 | 0.060 | ||||||
0-3 | 20 | 15 | 16 | 0-3 | 22 | 19 | 25 | ||||
3< | 3 | 4 | 6 | 3< | 11 | 3 | 3 | ||||
Nuclear grade | 70 | 0.838 | Nuclear grade | 91 | 0.022 | ||||||
1 | 12 | 12 | 9 | 1 | 8 | 10 | 21 | ||||
2 | 4 | 4 | 4 | 2 | 7 | 4 | 6 | ||||
3 | 9 | 6 | 10 | 3 | 19 | 9 | 7 | ||||
ER | 70 | 0.707 | ER | 93 | 0.027 | ||||||
Negative | 9 | 9 | 11 | Negative | 21 | 10 | 9 | ||||
Positive | 16 | 13 | 12 | Positive | 15 | 13 | 25 | ||||
PgR | 68 | 0.590 | PgR | 91 | 0.019 | ||||||
Negative | 10 | 9 | 12 | Negative | 21 | 13 | 10 | ||||
Positive | 14 | 13 | 10 | Positive | 13 | 10 | 24 | ||||
HER2 | 71 | 0.580 | HER2 | 93 | 0.082 | ||||||
Negative (0/1) | 20 | 15 | 19 | Negative (0/1) | 29 | 14 | 29 | ||||
Positive (2/3) | 5 | 7 | 5 | Positive (2/3) | 7 | 9 | 5 | ||||
Intrinsic subtype | 69 | 0.462 | Intrinsic subtype | 91 | 0.002 | ||||||
Luminal | 18 | 14 | 12 | Luminal | 14 | 14 | 28 | ||||
Non-luminal | 7 | 8 | 10 | Non-luminal | 20 | 9 | 6 | ||||
MIB-1 index | 69 | 0.482 | MIB-1 index | 91 | 0.001 | ||||||
<30 | 14 | 9 | 9 | <30 | 9 | 8 | 24 | ||||
30≦ | 11 | 13 | 13 | 30≦ | 25 | 15 | 10 |